The Medical Newsfrom News-Medical.Net - Latest Medical News and Research from Around the Worldhttp://www.news-medical.net/
en-GBNews-Medical.NetTests show VSV-ZEBOV vaccine safe and effective against EbolaTests of the experimental Ebola vaccine VSV-ZEBOV in over 7500 participants in Guinea suggest that the vaccine provides high protection against the disease as early as ten days after vaccination, in adults who have potentially been exposed to the virus by coming in close contact with a recently infected person.http://www.news-medical.net/news/20150731/Tests-show-VSV-ZEBOV-vaccine-safe-and-effective-against-Ebola.aspx
http://www.news-medical.net/news/20150731/Tests-show-VSV-ZEBOV-vaccine-safe-and-effective-against-Ebola.aspx#commenthttp://www.news-medical.net/post.aspx?id=846ac082-3d91-4939-bde6-66dd1a5587b3Fri, 31 Jul 2015 09:52:11 -0400New IMA device could improve diagnosis, treatment of chronic musculoskeletal painMore than 100 million people across Europe suffer from chronic musculoskeletal pain, with an estimated 40 per cent undiagnosed. Ageing populations throughout Europe means that this only going to increase in the coming years.http://www.news-medical.net/news/20150731/New-IMA-device-could-improve-diagnosis-treatment-of-chronic-musculoskeletal-pain.aspx
http://www.news-medical.net/news/20150731/New-IMA-device-could-improve-diagnosis-treatment-of-chronic-musculoskeletal-pain.aspx#commenthttp://www.news-medical.net/post.aspx?id=8d22378a-cea6-47ca-9cb0-763d87fa5591Fri, 31 Jul 2015 09:29:57 -0400FDA accepts Mundipharma EDO's Investigational New Drug Application for EDO-S101Mundipharma EDO GmbH (Early Development in Oncology) is pleased to announce that the United States Food and Drug Administration has accepted the company's Investigational New Drug Application ("IND") for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours.http://www.news-medical.net/news/20150731/FDA-accepts-Mundipharma-EDOs-Investigational-New-Drug-Application-for-EDO-S101.aspx
http://www.news-medical.net/news/20150731/FDA-accepts-Mundipharma-EDOs-Investigational-New-Drug-Application-for-EDO-S101.aspx#commenthttp://www.news-medical.net/post.aspx?id=5758b60f-d6b1-4609-8b91-e2e4e4e53288Fri, 31 Jul 2015 09:22:42 -0400Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancerEisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.http://www.news-medical.net/news/20150731/Eisai-Halozyme-partner-to-evaluate-eribulin-and-PEGPH20-in-HER2-negative-metastatic-breast-cancer.aspx
http://www.news-medical.net/news/20150731/Eisai-Halozyme-partner-to-evaluate-eribulin-and-PEGPH20-in-HER2-negative-metastatic-breast-cancer.aspx#commenthttp://www.news-medical.net/post.aspx?id=b3a5726d-9c56-4b9b-b4aa-a728081afe60Fri, 31 Jul 2015 09:19:21 -0400Guinea Phase III trial shows VSV-EBOV vaccine highly effective against EbolaResults from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola.http://www.news-medical.net/news/20150731/Guinea-Phase-III-trial-shows-VSV-EBOV-vaccine-highly-effective-against-Ebola.aspx
http://www.news-medical.net/news/20150731/Guinea-Phase-III-trial-shows-VSV-EBOV-vaccine-highly-effective-against-Ebola.aspx#commenthttp://www.news-medical.net/post.aspx?id=277b8176-6d97-42b5-8bf4-f30871ed83a7Fri, 31 Jul 2015 09:05:09 -0400Study evaluates costs and benefits of medical board recertification for improving healthcare qualityMany physicians are pushing back against or debating new requirements for maintaining medical board certifications, which affect more than 250,000 physicians nationwide. Now, a new study by UC San Francisco and Stanford University researchers concludes that the cost of implementing the most recent requirements will be an estimated $5.7 billion over the next 10 years.http://www.news-medical.net/news/20150731/Study-evaluates-costs-and-benefits-of-medical-board-recertification-for-improving-healthcare-quality.aspx
http://www.news-medical.net/news/20150731/Study-evaluates-costs-and-benefits-of-medical-board-recertification-for-improving-healthcare-quality.aspx#commenthttp://www.news-medical.net/post.aspx?id=64bf5716-1fb5-4e7c-bce3-eafff53287a9Fri, 31 Jul 2015 08:33:37 -0400University of Southampton research finds that electric fields alter behaviour of fruit fliesA new piece of research led by the University of Southampton has found that the behaviour of fruit flies, which are commonly used in laboratory experiments, is altered by electric fields.http://www.news-medical.net/news/20150731/University-of-Southampton-research-finds-that-electric-fields-alter-behaviour-of-fruit-flies.aspx
http://www.news-medical.net/news/20150731/University-of-Southampton-research-finds-that-electric-fields-alter-behaviour-of-fruit-flies.aspx#commenthttp://www.news-medical.net/post.aspx?id=a4c84a17-de91-40d7-b1b9-33f4ac33254fFri, 31 Jul 2015 08:27:38 -0400Teen scientist finds solution to tackle water quality issuesFor some of us it was an exciting time of creative experimentation. For others it was a time of botched and badly displayed data. For 16-year-old Maria Elena Grimmett, it's a blast. And she isn't peddling baking soda and vinegar volcanoes. Grimmett is tackling serious water quality issues that threaten the health of rivers, streams and groundwater. When she was just 14 years old, Grimmett was the youngest person published in the Journal of Environmental Quality.http://www.news-medical.net/news/20150731/Teen-scientist-finds-solution-to-tackle-water-quality-issues.aspx
http://www.news-medical.net/news/20150731/Teen-scientist-finds-solution-to-tackle-water-quality-issues.aspx#commenthttp://www.news-medical.net/post.aspx?id=22c7e7da-982c-4e94-bf9e-bbf9a6582ad3Fri, 31 Jul 2015 08:24:05 -0400Reducing incorrect gene expression can extend lifespan of cellsWorking with yeast and worms, researchers found that incorrect gene expression is a hallmark of aged cells and that reducing such "noise" extends lifespan in these organisms. The team published their findings this month in Genes & Development.http://www.news-medical.net/news/20150731/Reducing-incorrect-gene-expression-can-extend-lifespan-of-cells.aspx
http://www.news-medical.net/news/20150731/Reducing-incorrect-gene-expression-can-extend-lifespan-of-cells.aspx#commenthttp://www.news-medical.net/post.aspx?id=b4a1213d-f32e-4a5c-8014-2d084511b195Fri, 31 Jul 2015 08:20:31 -0400Magnaquest inks PoC with leading pharma giant for Internet of Things related initiativeMagnaquest, a leading Subscription Management, Billing and CRM solutions for video, data and cloud computing operators has signed a Proof of Concept (PoC) with a leading pharma giant for Internet of Things (IoT) related initiative.http://www.news-medical.net/news/20150731/Magnaquest-inks-PoC-with-leading-pharma-giant-for-Internet-of-Things-related-initiative.aspx
http://www.news-medical.net/news/20150731/Magnaquest-inks-PoC-with-leading-pharma-giant-for-Internet-of-Things-related-initiative.aspx#commenthttp://www.news-medical.net/post.aspx?id=d349113a-64ee-4205-b549-05b70d5c1626Fri, 31 Jul 2015 08:14:39 -0400